Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-10-25 08:01 | English | 1009.3 KB | |||
| 2017-10-24 15:00 |
Alligator Bioscience Aptevo Therapeutics: Tumor antigen 5T4 associated with man…
|
English | 299.7 KB | ||
| 2017-10-24 15:00 |
Alligator Bioscience och Aptevo Therapeutics: Tumörantigenet 5T4, uttryckt på m…
|
Swedish | 215.4 KB | ||
| 2017-10-16 15:15 | English | 34.2 KB | |||
| 2017-09-21 08:31 |
Alligator Bioscience to present ADC-1013 intratumoral clinical phase I study re…
|
English | 214.0 KB | ||
| 2017-09-21 08:31 |
Alligator Bioscience presenterar resultat från en klinisk fas I-studie (intratu…
|
Swedish | 214.7 KB | ||
| 2017-09-13 08:31 |
Alligator Bioscience signs immunotherapy research collaboration agreement for 4…
|
English | 397.4 KB | ||
| 2017-09-13 08:31 |
Alligator Bioscience tecknar forskningsavtal gällande 4-1BB för immunterapi
|
Swedish | 126.6 KB | ||
| 2017-08-23 08:30 | Swedish | 1.3 MB | |||
| 2017-08-23 08:30 | English | 1.3 MB | |||
| 2017-08-17 13:00 |
Aptevo Therapeutics och Alligator Bioscience inleder CTA-förberedande aktivitet…
|
Swedish | 683.3 KB | ||
| 2017-08-17 13:00 |
Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development …
|
English | 369.8 KB | ||
| 2017-07-21 07:01 |
Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel…
|
English | 368.4 KB | ||
| 2017-07-21 07:01 |
Aptevo Therapeutics och Alligator Bioscience inleder samutveckling av bispecifi…
|
Swedish | 758.9 KB | ||
| 2017-06-12 08:31 |
Alligator inleder preklinisk utveckling med den immunonkologiska 4-1BB antikrop…
|
Swedish | 417.5 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
